Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|19|7|757-776

ISSN： 1389-4501

Source： Current Drug Targets, Vol.19, Iss.7, 2018-04, pp. : 757-776

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

By Schwab M.   Klotz U.  

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 723-751

Adis International

Access to resources Recommend Favorite

New developments in the treatment of inflammatory bowel disease

By Keshavarzian Ali   Farhadi Ashkan   Mutlu Ece A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 365-385

Informa Healthcare

Access to resources Recommend Favorite

Can Surgery for Inflammatory Bowel Disease be Personalized?

By  

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 798-804

Bentham Science Publishers

Access to resources Recommend Favorite

Probiotic Lactobacilli: A New Perspective for the Treatment of Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 24, 2003-09 ,pp. : 1973-1980

Bentham Science Publishers

Access to resources Recommend Favorite

Budesonide: Teaching an Old Dog New Tricks for Inflammatory Bowel Disease Treatment

By  

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2527-2535

Bentham Science Publishers

Access to resources Recommend Favorite